Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


St. Jude Makes Change At The Top

This article was originally published in The Gray Sheet

Executive Summary

Daniel Starks is retiring as CEO of St. Jude Medical while Chief Operating Officer Michael Rousseau prepares to take the top spot on Jan. 1.

You may also be interested in...

People Briefs

Oncoming St. Jude CEO's executive team, Sorin and Cyberonics combined firm CFO, MITA chairman, and more personnel updates from around the industry.

VADs Set To Enter Big Leagues With St. Jude's Plan To Acquire Thoratec

St. Jude Medical says it will pay $3.4 billion to own ventricular-assist device leader Thoratec, pointing to significant synergies in the heart failure and interventional cardiology markets. The deal would thrust VADs into a diversified cardiology firm for the first time, and it includes a "go-shop" period that leaves an opening for other big device firms to enter competing bids.

St. Jude To Bring All Devices Under One Roof

St. Jude Medical plans to combine its implantable electronic device unit with its cardiovascular/ablation unit into one integrated R&D organization, and announced several senior leadership changes as part of the restructuring.


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts